| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 74, 1158-1163, Copyright © 1992 by Endocrine Society
ARTICLES |
ME Fant, L Nanu and RA Word
Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas 75235.
Endothelin-1 (Et-1) stimulated DNA synthesis in placental fibroblasts in a dose-dependent manner, as measured by [3H]thymidine incorporation (ED50, 0.2-0.3 ng/mL). Insulin-like growth factor-I (IGF-I) interacted synergistically with Et-1 to potentiate the stimulation of DNA synthesis. Additionally, Et-1 stimulated the turnover of phosphoinositides in a time- and concentration-dependent manner (ED50, 1 ng/mL), as measured by a 2- to 3-fold increase in the total accumulation of [3H]inositol phosphates. This was accompanied by a 2- to 3-fold rise in intracellular calcium, as measured by fura-2 fluorescence. IGF-I, however, had no potentiating effect on Et-1- stimulated phosphoinositide turnover or increase in cytosolic Ca2+. The ability of Et-1 to stimulate the production of IGF-II and IGFBPs by placental fibroblasts was then studied. Western ligand blot analysis using an [125I]IGF-II probe revealed the presence of six major binding proteins corresponding to 42, 38, 35, 32, 31, and 24 kilodaltons. Et-1 (50 ng/mL) stimulated all binding fractions concordantly. This was accompanied by a similar increase in immunoreactive IGF-II secretion, as assessed by a specific RIA. No increase in immunoreactive IGF-I was observed. The ability of the placenta to produce Et-1 was examined by Northern blot analysis. Placentae at 14 and 17 weeks gestation expressed small amounts Et-1 mRNA, whereas significantly higher levels of mRNA were expressed at term. These data suggest that the human placenta produces Et-1 in a developmentally regulated manner that may act via paracrine and/or autocrine mechanisms to regulate placental growth.
This article has been cited by other articles:
![]() |
D. Reiss, Y. Zhang, and D. L. Mager Widely variable endogenous retroviral methylation levels in human placenta Nucleic Acids Res., July 9, 2007; 35(14): 4743 - 4754. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cervar-Zivkovic, C. Hu, A. Barton, Y. Sadovsky, G. Desoye, U. Lang, and D.M. Nelson Endothelin-1 Attenuates Apoptosis in Cultured Trophoblasts From Term Human Placentas Reproductive Sciences, July 1, 2007; 14(5): 430 - 439. [Abstract] [PDF] |
||||
![]() |
A. Iwase, H. Ando, T. Nagasaka, D. Shibata, T. Harata, Y. Shimomura, M. Goto, and F. Kikkawa Neutral Endopeptidase Expressed by Decidualized Stromal Cells Suppresses Akt Phosphorylation and Deoxyribonucleic Acid Synthesis Induced by Endothelin-1 in Human Endometrium Endocrinology, November 1, 2006; 147(11): 5153 - 5159. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Radaelli, J. Uvena-Celebrezze, J. Minium, L. Huston-Presley, P. Catalano, and S. Hauguel-de Mouzon Maternal Interleukin-6: Marker of Fetal Growth and Adiposity Reproductive Sciences, January 1, 2006; 13(1): 53 - 57. [Abstract] [PDF] |
||||
![]() |
L. E. Spieker, G. Noll, F. T. Ruschitzka, and T. F. Luscher Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future? J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1493 - 1505. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Jauniaux, T.-M. Mignot, R. Rebourcet, B. Robert, and F. Ferre Placental endothelin gene expression and endothelin concentration in fetal fluids of the first trimester gestational sac Mol. Hum. Reprod., August 1, 2000; 6(8): 758 - 762. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Napolitano, F. Miceli, A. Calce, A. Vacca, A. Gulino, R. Apa, and A. Lanzone Expression and Relationship between Endothelin-1 Messenger Ribonucleic Acid (mRNA) and Inducible/Endothelial Nitric Oxide Synthase mRNA Isoforms from Normal and Preeclamptic Placentas J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2318 - 2323. [Abstract] [Full Text] |
||||
![]() |
P. Medstrand, J.-R. Landry, and D. L. Mager Long Terminal Repeats Are Used as Alternative Promoters for the Endothelin B Receptor and Apolipoprotein C-I Genes in Humans J. Biol. Chem., January 12, 2001; 276(3): 1896 - 1903. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |